Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000712786 | SCV000242275 | likely pathogenic | not provided | 2022-12-07 | criteria provided, single submitter | clinical testing | Intronic +5 splice site variant in a gene for which loss of function is a known mechanism of disease, and splice predictors support a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000471060 | SCV000543864 | uncertain significance | Progressive sclerosing poliodystrophy | 2022-11-04 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 6 of the POLG gene. It does not directly change the encoded amino acid sequence of the POLG protein. It affects a nucleotide within the consensus splice site. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with POLG-related conditions. ClinVar contains an entry for this variant (Variation ID: 206590). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Eurofins Ntd Llc |
RCV000712786 | SCV000707833 | uncertain significance | not provided | 2017-04-13 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712786 | SCV000843314 | uncertain significance | not provided | 2017-12-01 | criteria provided, single submitter | clinical testing |